You are here: Welcome to the MPKB » Welcome to the MPKB » Publications & presentations » Survey of Marshall Protocol patients with autoimmune diagnoses (2008)
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
home:publications:mp2008_survey [01.03.2012] – external edit 127.0.0.1home:publications:mp2008_survey [09.14.2022] (current) – external edit 127.0.0.1
Line 1: Line 1:
  ====== Survey of Marshall Protocol patients with autoimmune diagnoses (2008) ======  ====== Survey of Marshall Protocol patients with autoimmune diagnoses (2008) ======
 +
 +<relatedarticles> [[home:patients:cohort_statistics|Cohort statistics]], 
 + [[home:pathogenesis:innate_immunity|Innate immunity]], [[home:food:aim_health:aging|Research into protective effect of Olmesartan on various organs]]
 +</article>
  
 At the 6th International Congress on Autoimmunity in Porto, Portugal, Capt. Tom Perez MPH gave a presentation entitled [[perez_congress_on_autoimmunity_2008|Bacteria induced Vitamin D Receptor Dysfunction in Autoimmune Disease: Theoretical and practical Implications for Interpretation of Serum Vitamin D Metabolite Levels]]. The data in the presentation was based on a survey conducted over the course of 2007 and 2008 of 100 Marshall Protocol (MP) patients with autoimmune diagnoses. At the 6th International Congress on Autoimmunity in Porto, Portugal, Capt. Tom Perez MPH gave a presentation entitled [[perez_congress_on_autoimmunity_2008|Bacteria induced Vitamin D Receptor Dysfunction in Autoimmune Disease: Theoretical and practical Implications for Interpretation of Serum Vitamin D Metabolite Levels]]. The data in the presentation was based on a survey conducted over the course of 2007 and 2008 of 100 Marshall Protocol (MP) patients with autoimmune diagnoses.
Line 95: Line 99:
 {{tag> }} {{tag> }}
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
Line 101: Line 106:
   * I love this chart.  When I first saw it in the presentation on the link from the legacy site, it gave me a sense of the relative number of cohort members with various conditions, and gave me some documented evidence I could quote to friends with MP-treatable conditions.  The resolution of this chart on this site is much better than what I was originally able to see (from a photo showing the powerpoint in the background).  Even being able to read only the RA results clearly at that earlier time, it was helpful.  Shown clearly, I love it even more.  My one suggestion is that the link to this study, in Recovery Rate in the main Statistics article, is described only as methodology.  I was hoping to see the results, and seeing no link to results, I hit the methodology link just in case.  I'd like to see the link described as results AND methodology not just methodology, to make the info easier to find. -//Dody 2009/03/08//    * I love this chart.  When I first saw it in the presentation on the link from the legacy site, it gave me a sense of the relative number of cohort members with various conditions, and gave me some documented evidence I could quote to friends with MP-treatable conditions.  The resolution of this chart on this site is much better than what I was originally able to see (from a photo showing the powerpoint in the background).  Even being able to read only the RA results clearly at that earlier time, it was helpful.  Shown clearly, I love it even more.  My one suggestion is that the link to this study, in Recovery Rate in the main Statistics article, is described only as methodology.  I was hoping to see the results, and seeing no link to results, I hit the methodology link just in case.  I'd like to see the link described as results AND methodology not just methodology, to make the info easier to find. -//Dody 2009/03/08// 
   * It doesn't say how the patients were selected     * It doesn't say how the patients were selected  
-  * New sentence added to explain selection process.  --- //Joyful 05.27.2011//+  * New sentence added to explain selection process.  --- //Joyful 05.27.2011//</nodisp> 
home/publications/mp2008_survey.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.